Nephrostomy Devices Market To Reach USD 1.51 Billion By Boston Scientific Corp (U.S.), Teleflex, Inc. (U.S.), Cardinal Health (U.S.), Becton, Dickinson and Company (U.S.)

Rise in the kidney-related disorders worldwide, rise in geriatric population, increasing strategic initiatives such as product launch or collaboration are key factors contributing to a high CAGR of the Nephrostomy Devices during the forecast period.

Market Size – USD 831.8 Million in 2018, Market Growth – CAGR of 7.7%, Market Trends– Developments in nephrostomy devices

According to the current analysis of Reports and Data, the globalNephrostomy Devices Marketvalued at USD 831.8 million in 2018 and is expected to reach USD 1.51 billion by the year 2026 at a CAGR of 7.7%. Nephrostomy devices are used in treating the blocked ureters of the kidney and also to restore the urine flow from blocked ureters for better functioning of the organ. Blocked ureters cause a rise in the pressure in the kidneys that causes further damage to kidneys such as hydronephrosis. It is caused due to the blocked ureters. Ideally, nephrostomy catheters are used for the treatment. Rise incidences of hydronephrosis are expected to boost for nephrostomy devices market. However, the increase in the geriatric population, ovarian, and prostate cancers are expected to fuel the market in the forecast period. Nephrostomy is regarded as a first-line treatment for patients suffering from kidney stones larger than 2 cm. However, high expenditure of therapy, alternative substitutes for nephrostomy, and the procedure being slightly painful these factors are likely to restrain the market growth.

Get Free Sample PDF Copy of this Report at: https://www.reportsanddata.com/sample-enquiry-form/2712

The Asia Pacific region had marked a significant growth in the market due to the rise in the better reimbursement policies, better healthcare facilities, increased funding by the government for R&D activities in surgical devices and procedures.

key participants include Boston Scientific Corp (U.S.), Teleflex, Inc. (U.S.), Cardinal Health (U.S.), Becton, Dickinson and Company (U.S.), Cook Medical (U.S.), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark), Olympus Corp (Japan), Argon Medical (U.S.), and Uresil LLC (U.S.), are the key players of the Nephrostomy Devices market.Boston Scientific Corp (U.S.), Teleflex, Inc. (U.S.), Cardinal Health (U.S.), Becton, Dickinson and Company (U.S.), Cook Medical (U.S.), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark), Olympus Corp (Japan), Argon Medical (U.S.), and Uresil LLC (U.S.)

For the purpose of this report, Reports and Data has segmented the Nephrostomy Devices market on the basis of Products, end use and region:

Products Outlook (Revenue in Million USD; 2016–2026)

• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

End use(Revenue in Million USD; 2016–2026)

• Hospitals
• Emergency Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics

Regional Outlook (Revenue in Million USD; 2016–2026)

• North America
  • U.S
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Spain
  • Italy
  • Rest of the Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
• Middle East & Africa
• Latin America
  • Brazil

Ask For Discount at: https://www.reportsanddata.com/discount-enquiry-form/2712

Further key findings from the report suggest

• In 2016 the Biotherapy Researchers and Researchers of Rutgers Cancer Institute of New Jersey had conducted a study to evaluate the safe use of Nephrostomy Tube for Delivering chemotherapy. During the study, a nephrostomy tube was temporarily inserted into the patient’s body, and after surgery, the patient received either chemotherapy or biotherapy, like Bacillus Calmette–Gurin was directly given to the kidney for killing the tumor cells.
• ConvertX has modernized the procedure for nephrostomy earlier; a catheter was placed to drain urine into a bag, and then after few days, the catheter was, and then a stent was placed, but ConvertX was designed to have the stent delivered during catheter placement and is expanded after drainage is complete. The catheter transforms into a stent quickly without the need for fluoroscopy or sedating the patient the stent functions like other existing ureteral stents
• Cook Medical had launched Ultraxx Nephrostomy Balloon Catheter. It was used to dilate the musculofascia, renal capsule, and parenchyma and to maintain a percutaneous nephrostomy tract. Radiopaque markers were used that indicate the proximal and the distal end of the balloon. The balloon is designed with the burst pressure of 20 atm.
• Boston Scientific Corporation, in the year 2018, had launched LithoVue Empower Retrieval Deployment Device globally; it was designed to be used with the LithoVue.I t is a Single-Use Digital Flexible Ureteroscope that also contains a compatible nitinol retrieval basket that enables the urologists to operate a ureteroscope and basket simultaneously while retrieving kidney stones via flexible ureteroscopy.

Buy Full Report athttps://www.reportsanddata.com/checkout-form/2712

Tags: Nephrostomy Devices Market 2020, Nephrostomy Devices Market analysis, Nephrostomy Devices Market demand, Nephrostomy Devices Market forecast, Nephrostomy Devices Market growth, Nephrostomy Devices Market size